CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response

The ligand for CD40 (CD40L) is expressed on the surface of activated CD4+ T cells and its role in T-B cell collaborations and thymus- dependent humoral immunity is well established. Recently, by generating CD40L-knockout mice, we have confirmed its previously described role in humoral immunity and defined another important function of this molecule in the in vivo clonal expansion of antigen-specific CD4+ T cells. Here, we investigated the potential in vivo role of CD40L in antiviral immunity by examining the immune response mounted by CD40L- deficient mice following infection with lymphocytic choriomeningitis virus (LCMV), Pichinde virus, or vesicular stomatitis virus. Humoral immune responses of CD40L-deficient mice to these viruses were severely compromised, although moderate titres of antiviral IgM and some IgG2a were produced by virus-infected CD40L-deficient mice by a CD4+ T cell- independent mechanism. By contrast, CD40L-deficient mice made strong primary CTL responses to all three viruses. Interestingly however, although memory CTL activity was detectable in CD40L-deficient mice two months after infection with LCMV, the memory CTL response was much less efficient than in wild-type mice. Together, the results show that CD40- CD40L interactions are required for strong antiviral humoral immune responses, and reveal a novel role for CD40L in the establishment and/or maintenance of CD8+ CTL memory.

[1]  M. V. von Herrath,et al.  CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge , 1996, Journal of virology.

[2]  J. Banchereau,et al.  CD40-CD40 ligand: a multifunctional receptor-ligand pair. , 1996, Advances in immunology.

[3]  R. Flavell,et al.  Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.

[4]  J. Karras,et al.  Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. , 1995, Journal of immunology.

[5]  R. Zinkernagel,et al.  Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice , 1995, Journal of virology.

[6]  R. Ahmed,et al.  Bone marrow is a major site of long-term antibody production after acute viral infection , 1995, Journal of virology.

[7]  P. Borrow,et al.  Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression , 1995, Journal of virology.

[8]  C. Snapper,et al.  T cell-independent antigens type 2. , 1995, Annual review of immunology.

[9]  A. Fischer,et al.  T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand , 1994, The Journal of experimental medicine.

[10]  R J Armitage,et al.  Humoral immune responses in CD40 ligand-deficient mice , 1994, The Journal of experimental medicine.

[11]  R. Noelle,et al.  In vivo T-B cell interactions and cytokine-production in the spleen. , 1994, Seminars in immunology.

[12]  T. Foy,et al.  The expansive role of CD40 and its ligand, gp39, in immunity. , 1994, Seminars in immunology.

[13]  R. Flavell,et al.  Mice deficient for the CD40 ligand. , 1994, Immunity.

[14]  A. Saxon,et al.  CD58 (LFA-3) stimulation provides a signal for human isotype switching and IgE production distinct from CD40. , 1994, Journal of immunology.

[15]  R. Zinkernagel,et al.  Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice , 1994, Journal of virology.

[16]  D. Gray,et al.  Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction , 1994, The Journal of experimental medicine.

[17]  A. Aruffo,et al.  gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory , 1994, The Journal of experimental medicine.

[18]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[19]  Peter C. Doherty,et al.  Virus-specific CD8+ T-cell memory determined by clonal burst size , 1994, Nature.

[20]  R. Ahmed,et al.  Cytotoxic T-cell memory without antigen , 1994, Nature.

[21]  R. Zinkernagel,et al.  Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen , 1994, Journal of virology.

[22]  R. Zinkernagel,et al.  The influence of antigen organization on B cell responsiveness. , 1993, Science.

[23]  A. Aruffo,et al.  In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions , 1993, The Journal of experimental medicine.

[24]  A. Aruffo,et al.  In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39 , 1993, The Journal of experimental medicine.

[25]  A. Aruffo,et al.  The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. , 1993, Journal of immunology.

[26]  G. Mudde,et al.  Induction of IgE and IgG1 in human B cell cultures with staphylococcal superantigens: role of helper T cell interaction, resistance to interferon-gamma. , 1993, Immunobiology.

[27]  E. Maggi,et al.  Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells , 1993, Nature.

[28]  J. Whitton,et al.  A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge , 1993, Journal of virology.

[29]  J. Whitton,et al.  Molecular Anatomy of the Cytotoxic T-Lymphocyte Responses to Lymphocytic Choriomeningitis Virus , 1993 .

[30]  G. Inghirami,et al.  Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. , 1992, Journal of immunology.

[31]  I. Stamenkovic,et al.  The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity. , 1992, The EMBO journal.

[32]  C. Maliszewski,et al.  Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion , 1992, The Journal of experimental medicine.

[33]  D. Gray,et al.  Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes , 1992, European journal of immunology.

[34]  I. Stamenkovic,et al.  A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. F. Burton,et al.  Germinal Centers and Antibody Production in Bone Marrow , 1992, Immunological reviews.

[36]  L. Notarangelo,et al.  Immunodeficiency with hyper-IgM (HIM). , 1992, Immunodeficiency reviews.

[37]  R. Zinkernagel,et al.  Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression , 1991, The Journal of experimental medicine.

[38]  C. Biron,et al.  The role of CD4+ cells in sustaining lymphocyte proliferation during lymphocytic choriomeningitis virus infection. , 1991, Journal of immunology.

[39]  I. Maclennan,et al.  Mechanism of antigen-driven selection in germinal centres , 1989, Nature.

[40]  J. Whitton,et al.  Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes , 1989, The Journal of experimental medicine.

[41]  J. Whitton,et al.  Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. , 1988, Virology.

[42]  R. Ahmed,et al.  Immune therapy of a persistent and disseminated viral infection , 1987, Journal of virology.

[43]  D. Moskophidis,et al.  Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response , 1987, Journal of virology.

[44]  R. Zinkernagel,et al.  Functional analysis of T lymphocyte subsets in antiviral host defense. , 1987, Journal of immunology.

[45]  J. Holland,et al.  Continuing coevolution of virus and defective interfering particles and of viral genome sequences during undiluted passages: virus mutants exhibiting nearly complete resistance to formerly dominant defective interfering particles , 1987, Journal of virology.

[46]  D. Gray,et al.  Antigen‐Driven Selection of Virgin and Memory B Cells , 1986, Immunological reviews.

[47]  R. Zinkernagel,et al.  Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. , 1986, Journal of immunology.

[48]  R. Schreiber,et al.  Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. , 1985, Journal of immunology.

[49]  H. Waldmann,et al.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo , 1984, Nature.

[50]  R. Ahmed,et al.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence , 1984, The Journal of experimental medicine.

[51]  L. Lefrançois Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo , 1984, Journal of virology.

[52]  M. Oldstone,et al.  Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. , 1983, The Journal of general virology.

[53]  L. Lefrançois,et al.  The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies. , 1982, Virology.

[54]  R. Mannino,et al.  The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes , 1981, The Journal of experimental medicine.

[55]  M. Buchmeier,et al.  Protein structure of lymphocytic choriomeningitis virus: evidence for a cell-associated precursor of the virion glycopeptides. , 1979, Virology.

[56]  M. Buchmeier,et al.  Variation Between Strains of Hamsters in the Lethality of Pichinde Virus Infections , 1977, Infection and immunity.

[57]  I. Gresser,et al.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses , 1976, The Journal of experimental medicine.

[58]  D. H. Harter,et al.  NEUROPATHOLOGICAL AND IMMUNOFLUORESCENCE STUDIES OF EXPERIMENTAL VESICULAR STOMATITIS VIRUS ENCEPHALITIS IN MICE , 1971, Journal of neuropathology and experimental neurology.